Shares of Merck & Co. (MRK) rose 5% on Friday after the pharmaceutical giant reported positive developments across multiple oncology programs, reinforcing investor confidence in its efforts to extend ...

We just covered the 14 Best Low Risk High Growth Stocks to Buy Right Now and Merck & Co., Inc. (NYSE:MRK) ranks 6th on this list. It is no secret that the pharmaceutical industry is facing a ...

We recently published a list of the 20 Best Dividend Growth Stocks with High Yields. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best ...

We recently published a list of the 10 High Growth Forever Dividend Stocks to Invest In. In this article, we are going to take a look at where Merck & Co. Inc. (NYSE:MRK) stands against other high ...

The laryngeal cancer market is expanding due to advancements in treatment, early detection awareness, and diagnostic innovations, driven by rising cancer rates, especially in North America and ...

Merck & Co. agreed to buy Terns Pharmaceuticals Inc. for $6.7 billion, giving the multinational company access to a promising new leukemia treatment as it faces the patent expiration of its ...

Analysts' ratings for Merck & Co (NYSE:MRK) over the last quarter vary from bullish to bearish, as provided by 9 analysts. The table below provides a snapshot of their recent ratings, showcasing how ...

Disclosed in the latest SEC filing, a significant insider purchase on January 29, involves Robert M Davis, Chairman at Merck & Co (NYSE:MRK). What Happened: Davis's recent move, as outlined in a Form ...

Artisan Partners, an investment management company, released its “Artisan Value Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The growth stock trend that had ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...